Junctional Epidermolysis Bullosa clinical trials

Explore recruiting junctional epidermolysis bullosa clinical trials.

Recruiting junctional epidermolysis bullosa studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Junctional Epidermolysis Bullosa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)

Austria, Hungary, Poland, Italy, Germany, Denmark +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Junctional Epidermolysis Bullosa trials by city

Junctional Epidermolysis Bullosa clinical trials

Recruiting junctional epidermolysis bullosa studies right now

Gentamicin for Junctional Epidermolysis Bullosa

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Also recruiting in Europe

A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)

Junctional Epidermolysis Bullosa trials by city

Other conditions